Company Filing History:
Years Active: 2011
Title: Innovations of Ok Hui Park in Pharmaceutical Chemistry
Introduction: Ok Hui Park is a notable inventor based in Chungchongnam-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on thiourea derivatives. His research focuses on developing novel compounds that can modulate the activity of vanilloid receptors, which play a crucial role in pain management.
Latest Patents: Ok Hui Park holds 1 patent for his invention titled "Thiourea derivatives and the pharmaceutical compositions containing the same." This patent describes the development of new thiourea derivatives that serve as modulators for vanilloid receptors. The invention addresses various diseases associated with vanilloid receptor activity, including acute pain, chronic pain, neuropathic pain, and several other conditions such as asthma and inflammatory bowel disease. The pharmaceutical compositions derived from this invention aim to provide effective prevention and treatment options for these ailments.
Career Highlights: Throughout his career, Ok Hui Park has demonstrated a strong commitment to advancing pharmaceutical research. His work has not only contributed to the understanding of pain mechanisms but also paved the way for new therapeutic approaches. He is currently associated with Pacific Corporation, where he continues to innovate in the field of drug development.
Collaborations: Ok Hui Park has collaborated with esteemed colleagues, including Young Ger Suh and Uh Taek Oh, to further enhance the impact of his research. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their shared field of study.
Conclusion: Ok Hui Park's contributions to pharmaceutical chemistry, particularly through his patent on thiourea derivatives, highlight his role as an influential inventor. His work not only addresses critical health issues but also exemplifies the importance of innovation in the pharmaceutical industry.